Wockhardt denies media report on asset sale talks
MUMBAI (Reuters) - Generic drugmaker Wockhardt Ltd denied on Tuesday a media report that said U.S. drugmakers Mylan Inc and Pfizer Inc were in talks with the company to buy some of its assets.
Wockhardt cited the media report as saying that Mylan was in talks to buy its domestic business, while Pfizer was also in the race to buy some asset, as the company planned to focus only on overseas markets.
Shares in Wockhardt, which has been hit by a rash of regulatory sanctions due to poor manufacturing quality, ended up 12.1 percent at their highest close in nine months, having risen as much as 17.3 percent during the day in a weak Mumbai market.
"Presently we do not believe that there is any information/announcement of the nature sought by you," Wockhardt said in a statement to the exchanges. "In the event that there is any development that requires disclosure, we will make the same immediately in accordance with regulatory requirements."
(Reporting by Zeba Siddiqui in Mumbai; Editing by Anand Basu)
- Tweet this
- Share this
- Digg this
- China building South China Sea island big enough for airstrip - report
- Team mates will determine success of my captaincy - Kohli
- Bighorn sheep escapes Los Angeles Zoo, dies after car strikes it
- India approves $2.6 bln mounted gun purchase - official
- U.S. plans to arm Iraq's Sunni tribesmen with AK-47s, RPGs, mortars
India approved on Saturday the purchase of 814 mounted gun systems for the army at a cost of 157.5 billion rupees ($2.55 billion), a defence ministry spokesman said. Full Article